Continued approval for this indication may be contingent upon verification and description of clinical benefit in the phase 3 ACTION confirmatory trial ... Serious adverse reactions occurred in 33% of ...

Enrollment in the global Phase 3 MAGNITUDE trial of nexiguran ziclumeran (nex-z) in ATTR with cardiomyopathy (ATTR-CM) ...

As the Region of Waterloo finalizes its business case for phase two of the LRT project into Cambridge, residents have been ...

Industrial firms looking to electrify using renewable energy need cheap and efficient batteries to handle intermittency.

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Various sources corroborated Madi's death and that severe malnutrition was a factor, though there were reports he was also ...

Contemporary laboratories have become dependent on accurate temperature control as the key to good and repeatable experiments ...

Solid-state batteries ditch the liquid electrolyte for something solid, which makes them safer and longer-lasting. Iron-air ...

“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...

Strong execution and continued progress across pipeline Unprecedented data delivered from Phase 2 CSU study demonstrating ...

In the midst of a phase of reactions after the new policy announced in July by the US Olympic and Paralympic Committee, which ...

Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.